论文部分内容阅读
自1990年元月～1999年5月我科共收治HIE122例,均符合HIE的临床诊断标准。按照先后顺序分为常规治疗组50例。脑活素组42例,奥利达组30例,3组间一般资料经统计学处理差异无显著性。治疗方法:常规治疗组给予降颅压、止痉、吸氧,维持液体平衡及补充能量;在此基础上脑活素组加用脑活素5ml,每日1次静滴;奥利达组加用奥利达(成都地奥制药公司生产)5ml,每日1次静滴,10天～15天为一疗
From January 1990 to May 1999, our department received a total of HIE122 cases, are in line with the clinical diagnostic criteria HIE. In accordance with the order of 50 cases were divided into conventional treatment group. 42 cases of cerebrolysin group and 30 cases of orrital group. There was no significant difference in the general data between the 3 groups by statistical analysis. Treatment: Conventional treatment group given reduced intracranial pressure, antispasmodic, oxygen, to maintain fluid balance and supplement energy; on this basis, cerebrolysin plus cerebrolysin 5ml, intravenous infusion once daily; Olite group Plus Aoleida (Chengdu Austrian pharmaceutical company production) 5ml, intravenous infusion once a day, 10 days to 15 days for a treatment